Searchable abstracts of presentations at key conferences in endocrinology

ea0014s6.4 | Diabetes and insulin | ECE2007

Engineering beta cells to recover insulin function

Soria Bernat , Hmadcha A , Tejedo JR , Bedoya FJ , Martin F

Stem cells are clonogenic cells capable of both self-renewal and multilineage differentiation. Therefore, these cells have the potential to proliferate and differentiate into any type of cell and to be genetically modified ‘in vitro’, thus providing cells which can be isolated and used for transplantation. Moreover, these derived cells have proven to be useful in different animal models. Using a combination of several directed differentiation methods (nicotina...

ea0090p4 | Adrenal and Cardiovascular Endocrinology | ECE2023

Hypogonadism in men with congenital adrenal hyperplasia. A retrospective longitudinal analysis with a special focus on testicular adrenal rest tumors and 11-oxygenated androgens

Auer Matthias , Lottspeich Christian , Bidlingmaier Martin , F. Nowotny Hanna , Tschaidse Lea , Auchus Richard , Reisch Nicole

Background: Hypogonadism is frequent in men with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD). It has recently been demonstrated that testicular adrenal rest tumors (TART) are a source of 11-oxygenated androgens that might impair testicular function, in addition to their local compressive effects. Data on long-term course of testicular function in men with 21OHD and the role of potential influential factors such as presence of TART and 11-oxyge...

ea0026p191 | Pituitary | ECE2011

The treatment with dopamine agonists are not associated with increased prevalence of cardiac-valve regurgitation in patients with prolactinomas and acromegalia

Puma M , Lecumberri B , Fernandez A , Dominguez F , Martin M , Yanguela M , Pallardo L , Alvarez C

Background: Dopamine agonists are first-line agents for the treatment of prolactinomas and sometimes are used in patients with acromegalia. There is evidence that these drugs, especially cabergoline, are associated with an increased risk of new cardiac valve regurgitation in patients treated for Parkinson’s disease.Objective: Our objective was to evaluate the prevalence of cardiac valve regurgitation in patients with prolactinomas and acromegalia tr...

ea0037gp.26.09 | Thyroid – hypothyroidism | ECE2015

No effect of Thr92Ala DIO2 polymorphisms on thyroid parameters, health-related quality of life, and cognitive functioning

Wolffenbuttel Bruce H R , van Loon Hannah C M , Elderson Martin F , van Vliet-Ostaptchouk Jana V , Wouters Hanneke J C M , Kobold Anneke Muller , Links Thera P , Slagter Sandra N , van der Klauw Melanie M

Introduction: The Thr92Ala polymorphism of deiodinase 2 (DIO2) is associated with increased expression in the brain of genes associated with oxidative stress, and may predict favourable response to combination thyroxine (L-T4) plus triiodothyronine (T3) therapy. We examined whether the Thr92Ala polymorphism (rs225014) was associated with differences in thyroid hormone parameters, health-related quality of life (HR-QOL) and cognitive functio...